[Invasive treatment of phlegmasia cerulea dolens].
Marty
B
B
Service de chirurgie cardiovasculaire, Hôpital Universitaire de Lausanne. martyb@hopcantfr.ch
Depairon
M
M
D000208:Acute Disease; D000328:Adult; D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy; D011655:Pulmonary Embolism / Q000517:prevention & control; D012008:Recurrence; D012307:Risk Factors; D015607:Stents; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D013924:Thrombophlebitis / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
D005343:Fibrinolytic Agents